SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,318,000 | +774.7% | 23,762 | +516.9% | 0.00% | – |
| Q3 2014 | $265,000 | -84.8% | 3,852 | -76.9% | 0.00% | -100.0% |
| Q2 2014 | $1,746,000 | -5.6% | 16,659 | -25.3% | 0.00% | 0.0% |
| Q1 2014 | $1,849,000 | +216.1% | 22,288 | +146.5% | 0.00% | +100.0% |
| Q4 2013 | $585,000 | -3.6% | 9,043 | -5.5% | 0.00% | 0.0% |
| Q3 2013 | $607,000 | -19.7% | 9,573 | -46.8% | 0.00% | 0.0% |
| Q2 2013 | $756,000 | – | 18,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,223,182 | $387,189,000 | 7.66% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 78,486 | $3,295,000 | 0.56% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,485,288 | $104,382,000 | 0.46% |
| HARVEY CAPITAL MANAGEMENT INC | 34,800 | $1,460,000 | 0.45% |
| EMERALD ADVISERS, LLC | 148,232 | $6,223,000 | 0.38% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 148,411 | $6,233,000 | 0.27% |
| ArrowMark Colorado Holdings LLC | 15,500 | $651,000 | 0.18% |
| CR Intrinsic Investors, LLC | 118,161 | $4,963,000 | 0.17% |
| BB BIOTECH AG | 53,549 | $2,248,000 | 0.16% |
| TURNER INVESTMENTS LLC | 209,744 | $8,806,000 | 0.12% |